The widespread interest in GLP-1 receptor agonists for weight loss, particularly amid drug shortages, has renewed clinical and regulatory attention to their safety profile, yet the clinical profile of acute exposures remains poorly understood, wrote first author Jordan Miller, a researcher with The University of Texas at San Antonio, and colleagues
In addition, I had been struggling to lose weight for what felt like a decade
Some people notice it happening shortly after they start Mounjaro, while others experience it when their dose is increased
Starting Weight: Individuals with higher starting weights may experience greater early results, including a noticeable drop in the first month
How It Works Tesamorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile growth hormone and downstream IGF1, which selectively stimulates lipolysis in visceral adipose tissue while largely preserving subcutaneous fat and lean muscle
Tirzepatide adds GIP receptor agonism for greater potency, and retatrutide adds glucagon agonism for the most advanced metabolic support